AURAYO

Serial Number 98908148
688

Registration Progress

Application Filed
Dec 17, 2024
Under Examination
Sep 2, 2025
Approved for Publication
Jul 8, 2025
Published for Opposition
Jul 8, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 02, 2026 79 days

Trademark Image

AURAYO

Basic Information

Serial Number
98908148
Filing Date
December 17, 2024
Published for Opposition
July 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Sep 2, 2025
Application
Pending
Classes
005

Rights Holder

PRIOVANT THERAPEUTICS, INC.

03
Address
151 W. 42ND STREET, 15TH FLOOR
NEW YORK, NY 10036

Ownership History

PRIOVANT THERAPEUTICS, INC.

Original Applicant
03
NEW YORK, NY

PRIOVANT THERAPEUTICS, INC.

Owner at Publication
03
NEW YORK, NY

Legal Representation

Attorney
Lisa L. Mueller

USPTO Deadlines

Next Deadline
79 days remaining
NOA E-Mailed - SOU Required
Due Date
March 02, 2026
Extension Available
Until September 02, 2026

Application History

8 events
Date Code Type Description Documents
Sep 2, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 8, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 2, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 4, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 4, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease

Classification

International Classes
005